BWX Technologies
This is the archived full research. Read the story
The company that builds every reactor and makes all the fuel for the US Navy's nuclear submarines and carriers, plus a smaller business making parts for power plants.
The scores
Growth3/4 →
Revenue grew 18.3% in 2025, 18% in Q2 2026 (9% organic) and 10% in Q3 2026, and the naval half grew 2% then 4%.
Business quality3/4 →
The naval half is protected, the only two Category I plants, but the commercial third competes with Doosan and Framatome on price.
Financial position3/4 ↑
About $1.41B of net debt, roughly 2.1 times guided profit before depreciation, with notes due 2028 and 2029 to refinance.
Execution record4/4 →
Eight beats in eight quarters and the last Investor Day's targets exceeded: 15% yearly growth against mid-single digits promised.
Per share capture3/4 →
Shares flat at 92.0M and deals paid in cash, but buybacks stopped in 2026 and margins fell as acquisitions grew revenue.
Potential3/4 ↑
$8.4B of backlog and $3.1B of NNSA awards are committed; the commercial new-build wave is expected, not signed.
Risk profile3/4 →
One buyer, the US government, is 68% of revenue: disclosed, long-standing and survivable, but one budget decision moves it.
Valuation1/4 ↑
About 21.9 times operating profit before depreciation, 148% of a three-stage value near $80.93 at an 8% return: priced for perfection, beyond the 20% margin.
Evidence quality3/4 →
The moat, orders and price rest on filings, the NRC and CRS; the growth the price needs rests on management's plan.
If it works 0.9× · if it fails you keep about 77%.
The Verdict
We rate BWX Technologies unattractive. Two thirds of it is protected: the only maker of the Navy's reactors and their fuel, paid at cost plus a steady fee, so the business is solid. The price is full: about right for two more years of its own plan, with no credit for its 2030 targets. As a bet on commercial power plants it is expensive and defensive: little lost if that stalls, little gained if it works. Our view would change if the naval half keeps growing profit while the commercial half signs its first new-reactor order.
The long caseNuclear costs a lot to build and little to run, gas the reverse; with turbines sold out, extending old reactors is the cheapest new power.
How we weighed it
The price against our value
Against it
Price at 148% of our value
The price sits above our value and above the bull case.
The business
In its favour
Solid
The only maker of the Navy's reactors, paid at cost plus a steady fee.
Growth against what the price assumes
Cuts both ways
The plan needs an unsigned new-build order and faster shipyards.
What could go wrong
Against it
The government is most of sales, shipyards set the pace and commercial orders are contested.
Against competitors
Cuts both ways
No filed rival compares directly; against its own normal it is still dearer.
How its group is behaving
Cuts both ways
Aerospace and defense names move together on budgets.
The latest news and report
Cuts both ways
The last report showed a naval profit jump but no new-reactor order.
The evidence under this - 7 claims
Naval Reactors owns the designs, so the customer controls the technology and could in principle license a second maker; none is proposed (S01).
The 16.9 norm was struck when the company grew 5% to 8% a year; on the 2030 target midpoint the same company value is about 12 times (C11).
Government Operations revenue grew 2% in Q2 and 4% in Q3 2026 (C03), against the August guide of high-single-digit growth for the year.
- 2026-11-02editedQ3 release tightened the 2026 guide and gave a first 2027 outlook
Government Operations adjusted EBITDA fell in Q2 2026 (C03), and over half of Commercial's Q2 growth was acquired (C13).
First-half commercial bookings fell 36% (C04), and the growth target assumes new-build orders not yet signed (C29).
Commercial bookings fell to $464.0M in the first half from $721.6M a year earlier (C04).
- 2026-11-03editedQ3 2026 call restated the timing: still possible by year-end but now 'no later than about the first half' of 2027; the order is not signed.
- 2026-11-02editedQ3 2026 replaces Q2: the naval half's profit rose 22% after falling in Q2
The company
A nuclear submarine needs a reactor and enough fuel to run for decades. BWXT makes both. Its Lynchburg, Virginia plant builds the reactors and cores, and its Nuclear Fuel Services plant in Tennessee makes the fuel for every reactor the US Navy runs, from the Virginia-class submarines to the Ford-class carriers.
The other third of the company sells steam generators, reactor parts, fuel and repair services to power-plant owners. It is the only maker of heavy nuclear parts in North America, and most of its customers are Canadian utilities.
The evidence under this - 4 claims
How it makes money
About 68% of sales come from the US government. The Navy orders reactors and fuel years ahead and pays BWXT's allowed costs plus a fee, so the money is steady but the margin is capped.
The commercial half is paid by utilities, roughly half for manufacturing parts and half for services and engineering. That money depends on plants being refurbished or built, and BWXT has to win each job on price.
The evidence under this - 4 claims
Where the money comes from, stream by stream
| Stream | Share of sales (FY 2025) | How it earns it |
|---|---|---|
| Nuclear components and fuel | 56.1% | Naval reactors, cores and fuel for the Navy's submarines and carriers, plus valves and fittings. |
| Uranium processing and nuclear services | 12.7% | Downblending, depleted uranium and enrichment programmes for NNSA, and government site services. |
| Advanced reactor design and engineering | 4.6% | Government-funded microreactor and space reactor work, including Pele and now Janus. |
| Commercial nuclear manufacturing | 13.4% | Steam generators, reactor parts and CANDU fuel for utilities, mostly in Canada. |
| Commercial nuclear services and engineering | 13.2% | Plant inspection, refurbishment, engineering and the medical isotope business being sold. |
Who runs it
Rex Geveden has run BWXT since 2017. Over the last five years it beat its own growth targets, partly through acquisitions. Insiders own under 1% of the company, and the chief executive sold 40,000 shares in the past year under a plan set in advance.
Most of the yearly bonus rides on operating profit and cash, and the long-term award on profit and the return on money invested, so pay follows profit, not sales.
The evidence under this - 5 claims
Part of the 15% was bought: organic growth was 8.5%, and the Kinectrics acquisition added revenue the old targets never assumed.
Why it wins, and who could beat it
Why customers come back
The regulator has licensed exactly two plants in America to handle the highly enriched uranium naval fuel needs, and BWXT owns both. The reactor designs are classified, and the Navy has no second supplier to turn to.
So nobody can take this work away. But the protection does not mean high prices: the Navy pays cost plus a fee, and the shipyards set the pace, building barely more than one Virginia-class submarine a year against a goal of two.
The evidence under this - 4 claims
Naval Reactors owns the designs, so the customer controls the technology and could in principle license a second maker; none is proposed (S01).
The threat
The naval half has no rival. The commercial half does. Doosan in Korea supplied the big parts for every recent US reactor, and Curtiss-Wright sells pumps for the same design. Being North America's only heavy-parts maker wins no order on its own.
In newer markets, other companies are building the special fuel small reactors need, and four rivals were picked beside BWXT for the Army's microreactor programme.
The evidence under this - 5 claims
BWXT says reactor vendors such as Westinghouse and GE Vernova need very large components and it is adding about 40% to its heavy-component bay (S09).
The rivals: CW, BEP, CCJ, LEU, XE, STDN, and 3 more that are private, in-house or listed abroad.
Who else does this, rival by rival
| Ticker | Rival | Where it competes | How far along | Priced against it |
|---|---|---|---|---|
| Doosan EnerbilityPriced against it: Listed abroad | Commercial Operations | On sale | Listed abroad | |
| Not listed | FramatomePriced against it: Not listed | Commercial Operations | On sale | Not listed |
| CW | Curtiss-Wright, Naval & PowerPriced against it: Same product | Commercial Operations | On sale | Same product |
| AtkinsRéalis (Candu Energy) and AeconPriced against it: Listed abroad | Commercial Operations | On sale | Listed abroad | |
| BEP · CCJ | Westinghouse, Radiant, Antares and General Atomics in the Army's Janus programmePriced against it: One segment only | Government Operations | Announced | One segment only |
| LEU | Centrus Energy, for national-security enrichmentPriced against it: One segment only | Government Operations | Announced | One segment only |
| XE · STDN | TRISO-X (X-energy) and Standard NuclearPriced against it: One segment only | Government Operations | Announced | One segment only |
How big it could get
How big this could get
The naval prize is set by how many boats the Navy builds. The plan is two Virginia-class and one Columbia-class submarine a year, each needing one BWXT reactor, plus a carrier every four years.
Shipyards have built only 1.1 to 1.2 Virginia-class boats a year since 2022, so BWXT already makes over half of what the plan would need. Growth comes when the yards speed up, not from winning share.
The evidence under this - 3 claims
CRS reports the yards have built only 1.1 to 1.2 Virginia boats a year since 2022 and never 2.0 (C09).
Who has signed
The Navy and the nuclear weapons agency have signed: backlog reached $8.6B in September, up from $7.3B at the end of 2025, including a new $1.5B enrichment programme.
The commercial backlog rose to $2.1B from $1.6B, but a business bought on 1 July is part of it, and no large new-reactor order is signed.
The evidence under this - 3 claims
- 2026-11-02edited30 September backlog from the 10-Q: Commercial rose, partly by acquisition, and Government fell
Centrus says its AC100M is the only production-ready technology for national-security enrichment (C19), and management itself questions whether unobligated enrichment is commercially viable (S08).
Where the growth is coming from, business by business
Where the growth is coming from
| Business | Share of revenue | Growth: last quarter | Last half-year | Last year |
|---|---|---|---|---|
| Government Operations | 67% | +3.6% | +3.8% | +4.1% |
| Commercial Operations | 33% | +25.2% | +57.6% | +77.8% |
| Whole company | 100% | +9.9% | +17.0% | +20.1% |
The filed split through 2026-09-30. These rates are not carried forward: the reading below says why.
How we read it: The score believes the blend, not Commercial's 107%: that rate is mostly Kinectrics and PCG, bought, and the organic commercial rate was 33% in Q2 2026.
The results
The numbers
Sales grew 18% over the twelve months to Sep 2026, about the same pace as the 18% in the year to Dec 2025.
Operating margin is 12%, down from 15% in the year to Dec 2023.
Yearly sales growth has ranged from +0.0% to +18% over the last 5 years.
Each dollar put into the business earns 12% a year after tax, about where it was (16%) in the year to Dec 2021.
It turned 10% of sales into free cash, $372M over the last twelve months.
It owes $1.45B more than the cash it holds, about 2.5 years of the cash its operations bring in.
The share count fell 2.7% in 4.8 years, and pay in shares costs 1.0% of sales.
All the numbers
Filed figures from the company's 10-K and 10-Q, read 2026-11-10. Fiscal years end in December.
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | 12 mo to Sep 2026 | |
|---|---|---|---|---|---|---|
| Size and growth | ||||||
| Sales | $2.12B | $2.23B | $2.50B | $2.70B | $3.20B | $3.60B |
| Sales growth | +0.0% | +5.1% | +12% | +8.3% | +18% | +18% |
| Profit | ||||||
| Gross margin | 26% | 25% | 25% | 24% | 23% | - |
| Operating margin | 16% | 16% | 15% | 14% | 13% | 12% |
| Net margin | 14% | 11% | 9.8% | 10% | 10% | 10% |
| What growth costs, per sales dollar | ||||||
| Research and development | 0.5% | 0.4% | 0.3% | 0.3% | 0.4% | 0.4% |
| Selling, general and admin | 11% | 10% | 11% | 12% | 12% | 12% |
| Pay in shares | 0.9% | 0.7% | 0.6% | 0.8% | 0.8% | 1.0% |
| Capital spending | 15% | 8.9% | 6.1% | 5.7% | 5.8% | 5.7% |
| Cash | ||||||
| Cash from operations | $386M | $245M | $364M | $408M | $480M | $579M |
| Free cash flow | $75.0M | $46.4M | $212M | $255M | $295M | $372M |
| Balance sheet | ||||||
| Cash and short-term investments | $37.7M | $39.0M | $75.8M | $74.1M | $500M | $569M |
| Debt | $1.19B | $1.29B | $1.21B | $1.06B | $2.02B | $2.02B |
| Net cash | −$1.15B | −$1.25B | −$1.13B | −$981M | −$1.52B | −$1.45B |
| Returns and shares | ||||||
| Return on capital | 16% | 14% | 14% | 14% | 12% | 12% |
| Shares (diluted) | 94.5M | 91.7M | 91.9M | 91.9M | 91.9M | 92.0M |
What growth costs
Growing has made BWXT less profitable so far: the businesses it bought and the new government programmes earn thinner margins than naval reactors. Factories cost a steady slice of sales each year. The plan says margins recover by 2030; that is a promise, not yet a trend.
The evidence under this - 4 claims
Government Operations adjusted EBITDA fell in Q2 2026 (C03), and over half of Commercial's Q2 growth was acquired (C13).
The last report (2 Nov)
Quarter ended September 2026, filed figures.
Sales rose 10% to $953.0M in the third quarter of 2026. The naval half grew 4%, but its profit before interest, tax and depreciation rose 22% to $144.2M from $118.3M, after falling in the June quarter.
The commercial half grew 25% and its profit rose 17%. Its backlog reached $2.1B, but that includes a business BWXT bought on 1 July, and no large new-reactor order was reported.
The company tightened its 2026 forecast, to about $667M of profit and $4.72 to $4.77 a share, and gave a first 2027 outlook of high-single-digit sales growth.
What it did to the thesisIt did not move the view. The naval profit jump is the first support for the plan since the June fall, but it is one quarter, naval sales grew only slightly, and no new-reactor order came. The price still waits on the plan.
The quarter in detail
Sales growth from the previous quarter, filed figures.
Earnings per share $1.26 against $1.18 expected.
The evidence under this - 4 claims
- 2026-11-02editedQ3 2026 replaces Q2: the naval half's profit rose 22% after falling in Q2
- 2026-11-02edited30 September backlog from the 10-Q: Commercial rose, partly by acquisition, and Government fell
Government Operations revenue grew 2% in Q2 and 4% in Q3 2026 (C03), against the August guide of high-single-digit growth for the year.
- 2026-11-02editedQ3 release tightened the 2026 guide and gave a first 2027 outlook
What management did with the money
Management spent on growth: it bought Kinectrics and Precision Components Group to build the commercial half, and is selling the medical business for $750M. It plans no share buybacks in 2026, and borrowed $1.25B through bonds that convert into shares.
Insiders in 2026Q3: 5 purchases and 10 sales, from their Form 4 filings.
The evidence under this - 4 claims
- 2026-11-02edited30 September cash and debt from the Q3 release; the note terms are those read in the Q2 10-Q
The price, and where we disagree
In short. Priced for perfection. The price is about 148% of what we think the business is worth, at an 8% yearly return.
The shares are 44% below their high and close to their low for the year, while sales kept growing. That is the market paying less for the same business, not the business shrinking.
At its investor day on 29 September the company set 2030 targets of $5.5B to $6B of sales. The third-quarter report on 2 November gave naval profit growth but no new-reactor order; on the call the chief executive said a first one is possible by year-end and no later than the first half of 2027.
The evidence under this - 4 claims
Government Operations adjusted EBITDA fell in Q2 2026 (C03), and over half of Commercial's Q2 growth was acquired (C13).
- 2026-11-02editedQ3 2026 extends the run of beats to nine
Commercial bookings fell to $464.0M in the first half from $721.6M a year earlier (C04).
- 2026-11-03editedQ3 2026 call restated the timing: still possible by year-end but now 'no later than about the first half' of 2027; the order is not signed.
How we value it
- Method
- Cash the business will produce, in three stages
- Required return
- 8%
- Long-run growth
- 4%
- Moat
- An average moat
| Bear | Base | Bull | |
|---|---|---|---|
| Sales growth, years 1 to 3 | 5.9%, 4.8%, 4.9% | 11.9%, 9.5%, 9.8% | 14.9%, 11.9%, 12.2% |
| Normal operating margin | 11% | 13.7% | 15.1% |
| Return on new capital after year ten | 8% | 12% | 15% |
| Value a share | $37.86 | $80.93 | $111 |
- Price
- $120
- Priced on
- 6 Nov
- Price as a share of the base value
- 148%
- Starting growth the price pays for
- 29.9%
- Yearly return the price offers on the base case
- 6.9%
- Risk check: valued at 10%, the rate for a cyclical or indebted business
- $46.85
Where each figure comes from
| Figure | Source | Where exactly |
|---|---|---|
| Sales, the last twelve months | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 2 Nov 2026; the four quarters to that date. |
| Operating margin today | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 2 Nov 2026; the four quarters to that date. |
| Tax rate | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 2 Nov 2026; the four quarters to that date. |
| Sales per dollar of new capital | Filed report | Annual report (10-K) for the period to 31 Dec 2025, filed 23 Feb 2026: the year's sales over its operating capital. |
| Shares | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 2 Nov 2026; the diluted share count. |
| Cash and investments | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 2 Nov 2026; the balance sheet on that date. |
| Debt | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 2 Nov 2026; the balance sheet on that date. |
| Sales growth, years 1 to 3 | Analysts' forecasts | FMP's consensus for the years to 31 Dec 2026, 31 Dec 2027, 31 Dec 2028 and 31 Dec 2029: the average of 8 to 14 analysts' revenue estimates, 12.1%, 9.4%, 9.6%. FMP publishes how many analysts, not who they are. |
| Normal operating margin | Analysts' forecasts | FMP's consensus operating margin for the year to 31 Dec 2028, the average of 14 analysts' estimates, 16.2%, less stock pay of 1% of sales and less the 1.5% the analysts add back on their adjusted basis. FMP publishes how many analysts, not who they are. |
| Return on new capital after year ten | Our method's rule | Set by our reading of the moat: the 8% rate with none, 12% with an average one, 15% with a strong one; the bear case earns the rate. |
| The bear and bull cases | Our method's rule | Our method's spread: the bear case takes half the growth and a fifth off the margin, the bull a quarter more growth and a tenth more margin. |
| Price | Market price | FMP's closing price on 6 Nov 2026. |
What each case rests on
Bear caseGrowth runs at half the analysts' path, 6%, 5% and 5%, the margin settles a fifth lower at 11.0%, and new capital earns only the 8% rate: the downturn test.
Base caseRevenue grows 12%, 10% and 10% over three years, the analysts' path (C56), then fades toward 4%, closing 30% of the gap each year; the margin moves to 13.7%, the analysts' year-three figure after stock pay and on the filed basis (1.5% less).
Bull caseGrowth runs a quarter above the analysts' path, 15%, 12% and 12%, the margin reaches 15.1%, and new capital earns 15%.
What moves the base value
| Lower | Higher | |
|---|---|---|
| Growth in years 1 to 3, a quarter lower or higher | $73.36 | $89.21 |
| The normal margin, 15% lower or higher | $65.69 | $96.16 |
| Capital per dollar of growth, a quarter more or less | $76.50 | $83.58 |
| Return on new capital after year ten, at the rate or one step up | $60.74 | $89.00 |
| The rate, a point higher or lower | $60.46 | $115 |
| Long-run growth a point lower | $71.31 | - |
Value a share as growth and margin change
| Normal margin ↓ · growth → | 50% | 75% | 100% | 125% | 150% |
|---|---|---|---|---|---|
| 11% | $50.18 | $55.15 | $60.62 | $66.60 | $73.15 |
| 12.3% | $58.32 | $64.26 | $70.77 | $77.91 | $85.71 |
| 13.7% | $66.47 | $73.36 | $80.93 | $89.21 | $98.28 |
| 15.1% | $74.61 | $82.47 | $91.08 | $101 | $111 |
| 16.4% | $82.76 | $91.57 | $101 | $112 | $123 |
Growth is shown as a share of the base case's. Green: the price is at or under 80% of that value. Red: at or over 120%.
How we read the multiple
A buyer today pays for the whole company, debt included, against the profit it expects this year before interest, tax and depreciation.
To be back at its usual valuation, BWXT has to earn about $815M of that profit, against about $667M this year. On the company's own 2030 plan, that arrives between 2027 and 2028.
So the price is not stretched, but it already counts the next two years of growth. A buyer gains from here only if growth comes faster than the plan.
Against its own history. Buyers still pay more for each dollar of profit than they usually have, so the fall removed the nuclear-boom excitement without making the shares cheap.
The evidence under this - 4 claims
The 16.9 norm was struck when the company grew 5% to 8% a year; on the 2030 target midpoint the same company value is about 12 times (C11).
Government Operations revenue grew 2% in Q2 and 4% in Q3 2026 (C03), against the August guide of high-single-digit growth for the year.
- 2026-11-02editedQ3 release tightened the 2026 guide and gave a first 2027 outlook
Government Operations adjusted EBITDA fell in Q2 2026 (C03), and over half of Commercial's Q2 growth was acquired (C13).
Priced against its rivals
Only Curtiss-Wright sells the same thing to the same buyers as a large part of what it does. A price comparison needs at least two, so the price is judged against its own history instead.
Private or foreign rivals that cannot be priced: Framatome, Westinghouse Electric Corporation, Bechtel National, Inc., Doosan Enerbility (formerly Doosan Heavy Industries & Construction), AECON Group Inc., AtkinsRéalis.
The bet: what it pays if it works
The bet is the commercial half: power-plant parts and services, and new reactors if orders come. The naval half is the floor.
The long case in the verdict is the chief executive's, and its direction checks out, though his gas fuel figure is generous. The work it favours is what Canadian utilities already buy from BWXT.
At the investor day pace the shares are worth their price; they pay well only if new-reactor orders come early.
| Commercial Operations EBITDA in two to three years | Dollars of commercial adjusted EBITDA needed | At the stated multiple |
|---|---|---|
| $145.00M | about 145.0M at 100% kept | 0.8× |
| $210.00M (the big win) | about 210.0M at 100% kept | 0.9× |
| $300.00M | about 300.0M at 100% kept | 1.0× |
To pay 2× (a Fair bet) it would need about $983.64M of Commercial Operations EBITDA (about 983.6M dollars of commercial adjusted EBITDA); to pay 5× (a Cheap bet), about $3.12B of Commercial Operations EBITDA (about 3.1B dollars of commercial adjusted EBITDA), at the same multiple.
Each row is Commercial Operations alone, plus the rest of the company (Government Operations) counted at about $8.79B.
The steps it has to take
- Done Kinectrics acquired
- Done Precision Components Group acquired
- In progress Medical business sold to Nordic Capital due 2027-03
- Not started First new-build large reactor equipment order signed due 2026-12
- Not started Commercial EBITDA margin reaches the 2030 high teens due 2030-12
The detail behind the label
The evidence under this - 6 claims
First-half commercial bookings fell 36% (C04), and the growth target assumes new-build orders not yet signed (C29).
Commercial bookings fell to $464.0M in the first half from $721.6M a year earlier (C04).
- 2026-11-03editedQ3 2026 call restated the timing: still possible by year-end but now 'no later than about the first half' of 2027; the order is not signed.
Government Operations adjusted EBITDA fell in Q2 2026 (C03), and over half of Commercial's Q2 growth was acquired (C13).
Government Operations grew 2% in Q2 2026 and its adjusted EBITDA fell (C03).
- At US gas prices and heat rates the fuel gap is about four times, not nearly seven: about $219M against $50M a gigawatt-year (C51).
- IAEA counts 446 reactors connected to the grid from 1970 to 1999, not about 600, and never more than 33 in a year where he said 15 or 20 a month (C53).
First-half commercial bookings fell and the commercial backlog was flat, so the tailwind has not yet shown up in orders (C04).
Where we disagree with the market
A nuclear-boom stock: small reactors, new power plants and AI power demand, now cheaper after a 44% fall.
Two thirds of it is a naval monopoly growing sales about 5% a year; its profit rose 22% last quarter after falling in the one before.
The boom story is mostly priced on businesses that earn little today: Army microreactors pay only on milestones into the 2030s, and new power-plant orders are not signed. What pays the bills is the Navy, and it grows at the pace of the shipyards.
Against us: analysts have turned more positive this year, and the company beat estimates in each of the last nine quarters.
What analysts say, and the evidence
The evidence under this - 5 claims
- 2026-11-02editedQ3 2026 replaces Q2: the naval half's profit rose 22% after falling in Q2
Naval Reactors owns the designs, so the customer controls the technology and could in principle license a second maker; none is proposed (S01).
What could go wrong, and how we would know
The risks
- One buyer The US government is 68% of sales. A budget fight or a slower shipbuilding plan hits most of the company at once.
- Shipyards set the pace BWXT cannot build reactors faster than the yards take them, and the yards have missed the two-a-year goal for over a decade.
- Commercial orders are contested Doosan, Framatome and Curtiss-Wright sell the same parts, so a new-build boom need not mean BWXT orders.
- Naval margins uneven Naval profit fell in the June quarter and rose 22% in the September one while new programmes ramped; if it swings back, the steady half stops being steady.
- New programmes are long dated Microreactors and enrichment pay on milestones over years and may never earn a commercial return.
The evidence under this - 6 claims
BWXT says reactor vendors such as Westinghouse and GE Vernova need very large components and it is adding about 40% to its heavy-component bay (S09).
- 2026-11-02editedQ3 2026 replaces Q2: the naval half's profit rose 22% after falling in Q2
- 2026-11-02edited30 September cash and debt from the Q3 release; the note terms are those read in the Q2 10-Q
What we still do not know
- What the Navy actually pays BWXT for one reactor and its core: only whole-boat costs and segment totals are public.
- Whether naval profit growth of 22% in the September quarter is new programmes maturing or timing: the company names programmes, not the arithmetic.
- Whether any new US or Canadian reactor order goes to BWXT rather than Doosan or Framatome.
The evidence under this - 3 claims
Naval Reactors owns the designs, so the customer controls the technology and could in principle license a second maker; none is proposed (S01).
- 2026-11-02editedQ3 2026 replaces Q2: the naval half's profit rose 22% after falling in Q2
Commercial bookings fell to $464.0M in the first half from $721.6M a year earlier (C04).
- 2026-11-03editedQ3 2026 call restated the timing: still possible by year-end but now 'no later than about the first half' of 2027; the order is not signed.
What would change our view
- Unattractive→NeutralThe price falls back within 20% of fair value
It needs:
- ○The share price falls to about $97.12, back within 20% of what we think the business is worth.about ≈$99.87 today, 29% below the last close
- Unattractive→AttractiveThe price falls 20% under fair value
It needs:
- ○The share price falls to about $64.74, 80% of what we think the business is worth.about ≈$70.95 today, 49% below the last close
- Unattractive→AttractiveThe plan arrives faster than the price needs
It needs all of:
- ○The naval half grows its profit at least 8% from a year earlier in the fourth quarter of 2026.checked at the next results, due by 1 Mar
- ○BWXT signs an equipment order for a new large reactor, as management expects by year-end.watched as it happens
We would also be wrong if
- A second company is licensed to make naval reactor fuel or cores.
- Congress funds fewer than two Virginia-class submarines a year again, or slows the Columbia class.
What is coming
- December 2026 First new-build reactor equipment order: Whether the commercial plan's high-teens growth has an order behind it, and whether BWXT or Doosan wins it.
Every dated event ahead
- December 2026 First new-build reactor equipment order: Whether the commercial plan's high-teens growth has an order behind it, and whether BWXT or Doosan wins it.
- February 2027 Q4 2026 results and the 2026 10-K: 2026 against the $667M guide, 2027 guidance, and Government Operations' full-year growth.
- March 2027 Medical sale closes: About $750M of cash that cuts net debt roughly in half, and the perimeter the 2027 guide is struck on.
- December 2028 Janus groundbreaking at Fort Campbell: Whether BANR moves from selection to construction on the Army's milestone payments.
Since we wrote this
- 9 NovThesis reviewUnattractive: priced at 144% of a value near $82.82Re-valued in three stages at an 8% return, the method now drawn on every thesis: the price sits beyond the 20% margin of safety.
- 4 NovNewsBWXT is replacing $800M of 4.125% notes with a $500M new issue and cash. View heldRefinancing of the 2028 and 2029 notes.
- 3 NovEarningsQ3 call: first reactor order possible by year-end, mid-2027 at latestManagement explained the naval profit jump and gave a softer date for the first new-reactor order; nothing signed, so Neutral at Medium holds.
- 2 NovEarningsNaval profit rose 22% in Q3; no new-reactor order yetGovernment Operations profit jumped after June's fall, but sales grew 4% and the commercial order is still unsigned, so Neutral at Medium holds.
- 13 OctBet moveBet re-struck: Priced for success to Safe, little upsideRe-priced at the 12 October close.
- 10 OctBet moveBet re-struck: Safe, little upside to Priced for successRe-priced at the 9 October close.
- 8 OctBet moveBet re-struck: Priced for success to Safe, little upsideRe-priced at the 7 October close.
- 7 OctBet moveBet re-struck: Safe, little upside to Priced for successRe-priced at the 6 October close.
- 6 OctNewsBWXT's small reactor is picked for a Canadian transportable nuclear plant project. View heldBANR microreactor chosen for a Canadian transportable nuclear plant project.
- 5 OctThesis writtenNeutral, medium convictionWritten a week after the Investor Day and four weeks before Q3 2026 results, with the shares 44% below their high.
- 5 OctThesis reviewOwner asked: the investor-day case for nuclear over gasThe owner asked why the chief executive's argument on fuel cost, turbine waits and life extension was missing; the first pass read the Investor Day for its targets only.
Also checked 3 times with nothing new to act on.
Sources 29
Sources - 29
Every claim above cites one of these, or states the reasoning that derived it. The quote is frozen at the date it was read: a link can rot, and an agent fetch returns a reading of a page rather than the page. Backs counts the whole claim ledger, so it can name a claim this page does not surface.
- S01primarycompany filing2026-02-23segments, facilities, competition, contract pricing, customer concentration, product-line and geographic revenue, acquisitions, cash flow and buybacksbacksC01C02C05C06C07C08C13C24C27C43C44
- S02primarycompany filing2026-08-03segment results, backlog and its unfunded part, debt and convertible terms, cash, the medical sale and the PCG acquisitionbacksC04C13C21C23C35
- S03primarycompany release2026-02-232025 adjusted EBITDA, non-GAAP EPS and free cash flow, and the first 2026 guidancebacksC02
- S04primarycompany release2026-08-03the quarter by segment, the adjusted EBITDA reconciliation, backlog and bookings, share counts and raised 2026 guidancebacksC13C21C24
- S05primaryregulator2026-10-05U.S. Nuclear Regulatory Commission: Fuel Fabrication U.S. Nuclear Regulatory Commissionthe two Category I licensees and the new Category II TRISO applications
Two Category I fuel fabrication plants are currently licensed by the NRC: Nuclear Fuel Services (NFS) in Erwin, Tennessee and the BWXT Nuclear Operations Group plant in Lynchburg, Virginia.
backsC06C17 - S06primarycompany release2026-10-01the contract's size and end date and the ship classes BWXT reactors power
BWXT’s Nuclear Fuel Services facility processes highly enriched uranium to manufacture fuel for all U.S. naval nuclear reactors
backsC07 - S07primarygovernment data2026-01-26Congressional Research Service RL32418: Navy Virginia-Class Submarine Program and AUKUS Submarine (Pillar 1) Project Congressional Research Serviceboats bought and built a year, their cost, and the 2.0 and 2.33 goals
the actual Virginia-class production rate has never reached 2.0 boats per year, and since 2022 has been limited to about 1.1 to 1.2 boats per year
backsC09 - S08primarytranscript2026-08-03BWXT Q2 2026 earnings call transcript (FMP)the Navy plan, the new-build order expectation, TRISO capacity, DUECE progress, capital spending and the medical sale
we believe there's a credible opportunity to secure at least one new build nuclear equipment order before the year-end
backsC10C12C17C18C24C29C35C44 - S09primarytranscript2026-09-29the 2030 targets by segment, the DUECE and HPDU awards, content per reactor, the record against the last targets and capital allocation
On revenue, we're targeting $5.5 billion-$6 billion in 2030, which is a low double-digit annual growth rate from 2026.
backsC10C11C18C28C37C43C44C50 - S10secondarygovernment data2026-08-31U.S. Army release on the Janus selection, as reproduced by Soldier Systems Daily U.S. Department of the Armyfive vendors, up to $2.2B over FY2027 to FY2031, milestone payments, contractor ownership; army.mil returned 403
Using a milestone-based payment model, vendors will receive government funding only after successfully hitting specific technical goals.
backsC14 - S11primarycompany release2026-08-26the Fort Campbell site, the 20 MWe design, the schedule and the Tata letter of intent
BWXT is targeting groundbreaking for site construction in late 2028 with reactor operations commencing in the early 2030’s.
backsC14 - S12secondarynews2008-06-05World Nuclear News: Doosan awarded further contract by Westinghouse World Nuclear NewsDoosan's steam generators and reactor vessels for Vogtle 3 and 4 and V.C. Summer 2 and 3
Doosan has been selected to supply major equipment to all four units of US AP1000s
backsC15 - S13primarytranscript2026-08-06Centrus Energy Q2 2026 earnings call transcript (FMP) Centrus Energya rival's claim on national-security enrichment
Centrus is the only viable production-ready technology that can meet national security needs
backsC19 - S14secondaryvendor data2026-10-05Research pack (FMP market data, FINRA, SEC filed figures), frozen as research-pack.jsonprice, the price decomposition, multiples against their history, earnings history, the analyst series, short interest, insider base rate and the five-year margin seriesbacksC20C21C25C26C38C43
- S15primarycompany filing2026-03-18officers' biographies, beneficial ownership and the bonus and performance unit plans with their 2025 payoutsbacksC40C41C42
- S16primarycompany filing2026-02-12its AP1000 reactor coolant pumps and control rod drives, naval propulsion products and Naval & Power segment salesbacksC16C36
- S17primarycompany filing2026-08-12each open-market sale with its 10b5-1 flagbacksC25
- S18secondaryvendor data2026-10-05FMP trailing key metrics for Curtiss-WrightCurtiss-Wright's company value against trailing EBITDAbacksC36
- S19primarygovernment data2025-10-01EIA Electric Power Annual, Table 8.1: average operating heat rate by energy source, 2014-2024 U.S. Energy Information Administrationnatural gas plants averaged 7,754 Btu per kWh in 2024
Table 8.1. Average Operating Heat Rate for Selected Energy Sources, 2014 through 2024 (Btu per Kilowatthour)
backsC51 - S20primarygovernment data2026-09-01FRED series MHHNGSP: Henry Hub natural gas spot price, monthly (EIA) U.S. Energy Information Administrationmonthly averages September 2025 to August 2026: $2.77 to $7.72, mean $3.59
Henry Hub Natural Gas Spot Price, Dollars per Million Btu, Monthly
backsC51 - S21primaryregulator2025-06-01IAEA Reference Data Series No. 2, 2025 edition: Nuclear Power Reactors in the World International Atomic Energy Agencygrid connections by year (446 from 1970 to 1999, at most 33 in a year) and the age of the operating fleet
About 67% of global operational reactor capacity (264.3 GW(e), 298 reactors) has been in operation for over 30 years, 35% (136.4 GW(e), 168 reactors) of the total installed capacity has been in operation for over 40 years.
backsC53 - S22primarycompany filing2026-07-22116 GW of gas turbines under contract against 20 GW of yearly output, 24 GW in 2028 and 30 GW planned for 2030
Gas Power equipment backlog and slot reservation agreements grew from 100 to 116 GW; now anticipate reaching at least 125 GW by year-end 2026
backsC52 - S23secondaryindustry data2026-06-05ANS Nuclear Newswire: North American construction is back, smaller and faster, at OPG's Darlington American Nuclear Societythe C$12.8B refurbishment of Darlington's four 878-MWe units, extending their lives by 30 years, and the C$20.9B envelope for four 300-MWe BWRX-300s at the same site
OPG is working with a C$20.9 billion project envelope and a similar strategy for the DNNP.
backsC54 - S24primarygovernment data2025-10-01EIA Electric Power Annual, Table 8.4: average power plant operating expenses, investor-owned utilities, 2014-2024 U.S. Energy Information Administrationnuclear fuel cost 6.37 mills per kWh in 2024, from FERC Form 1
Table 8.4. Average Power Plant Operating Expenses for Major U.S. Investor-Owned Electric Utilities, 2014 through 2024 (Mills per Kilowatthour)
backsC51 - S25primarycompany release2026-11-02the quarter by segment, adjusted EBITDA, tightened 2026 guidance, the preliminary 2027 outlook and the balance sheetbacksC03C12C23C38
- S26primarycompany filing2026-11-02backlog by segment, the PCG acquisition of 1 July 2026 and the medical sale agreement of 31 July 2026backsC03C04
- S27primarytranscript2026-11-02BWXT Q3 2026 earnings call transcript (FMP), held 2026-11-02the timing of the first new-build order, the Government Operations margin drivers, the 2027 outlook, and the gate on large-reactor decisions
I said at the beginning of this year that I expected us to have new orders for U.S. reactor plant builds in -- by the end of this year. And I still think that's a possibility for us, but certainly no later than about the first half of the next year.
backsC29 - S28primarycompany filing2026-11-09trailing revenue, operating profit, stock pay, tax, debt, cash and the diluted share countbacksC57
- S29secondaryvendor data2026-11-09the analysts' average revenue and operating profit for the next three fiscal years, and the closebacksC56C57